These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29999138)

  • 1. [Spirometric caracterization of cystic fibrosis patients].
    Pezoa A; Jorquera P; Madrid R; Maturana P; Viviani P; Caussade S
    Rev Chil Pediatr; 2018 Jun; 89(3):332-338. PubMed ID: 29999138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF registry.
    Stanojevic S; Stocks J; Bountziouka V; Aurora P; Kirkby J; Bourke S; Carr SB; Gunn E; Prasad A; Rosenfeld M; Bilton D
    J Cyst Fibros; 2014 May; 13(3):319-27. PubMed ID: 24332996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis.
    Assayag D; Vittinghoff E; Ryerson CJ; Cocconcelli E; Tonelli R; Hu X; Elicker BM; Golden JA; Jones KD; King TE; Koth LL; Lee JS; Ley B; Shum AK; Wolters PJ; Ryu JH; Collard HR
    Respir Med; 2015 Aug; 109(8):1058-62. PubMed ID: 26140806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.
    Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
    BMC Pulm Med; 2012 Sep; 12():50. PubMed ID: 22950544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.
    Rosenfeld M; VanDevanter DR; Ren CL; Elkin EP; Pasta DJ; Konstan MW; Morgan WJ;
    Pediatr Pulmonol; 2015 Sep; 50(9):856-62. PubMed ID: 26086901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New international reference values for spirometry: implications for clinical issues using a comparative analysis of a paediatric population].
    Lex C; Korten I; Hofmann A; Renner S; Szepfalusi Z; Frischer T; Zacharasiewicz A
    Wien Med Wochenschr; 2015 Sep; 165(17-18):361-5. PubMed ID: 26376983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-bronchodilator spirometry reference values in adults and implications for disease management.
    Johannessen A; Lehmann S; Omenaas ER; Eide GE; Bakke PS; Gulsvik A
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1316-25. PubMed ID: 16556696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker.
    Bakker EM; Borsboom GJ; van der Wiel-Kooij EC; Caudri D; Rosenfeld M; Tiddens HA
    Pediatr Pulmonol; 2013 Nov; 48(11):1081-8. PubMed ID: 23401260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of lung function decrements in children and adolescents with cystic fibrosis using new reference values.
    Zacharasiewicz A; Renner S; Haderer F; Weber M; Dehlink E; Szepfalusi Z; Frischer T
    Wien Klin Wochenschr; 2017 Aug; 129(15-16):533-539. PubMed ID: 28281010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry.
    Quanjer PH; Brazzale DJ; Boros PW; Pretto JJ
    Eur Respir J; 2013 Oct; 42(4):1046-54. PubMed ID: 23520323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of bronchodilator responsiveness in cystic fibrosis.
    Hordvik NL; König P; Morris D; Kreutz C; Barbero GJ
    Am Rev Respir Dis; 1985 Jun; 131(6):889-93. PubMed ID: 4003942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis and pregnancy.
    Jankelson D; Robinson M; Parsons S; Torzillo P; Peat B; Bye P
    Aust N Z J Obstet Gynaecol; 1998 May; 38(2):180-4. PubMed ID: 9653856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR.
    Rowe SM; McColley SA; Rietschel E; Li X; Bell SC; Konstan MW; Marigowda G; Waltz D; Boyle MP;
    Ann Am Thorac Soc; 2017 Feb; 14(2):213-219. PubMed ID: 27898234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spirometric values in healthy Chilean children and adolescents].
    Caussade S; Contreras I; Villarroel L; Fierro L; Sánchez I; Bertrand P; Holmgren NL
    Rev Med Chil; 2015 Nov; 143(11):1386-94. PubMed ID: 26757862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function between 40 and 80 years of age.
    Ostrowski S; Grzywa-Celińska A; Mieczkowska J; Rychlik M; Lachowska-Kotowska P; Lopatyński J
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():127-33. PubMed ID: 16204786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of spirometric reference values in Chilean children].
    Alvarez CG; Brockmann PV; Bertrand PN; Caussade SL; Campos EM; Sánchez ID
    Rev Med Chil; 2004 Oct; 132(10):1205-10. PubMed ID: 15631208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial.
    Davies J; Sheridan H; Bell N; Cunningham S; Davis SD; Elborn JS; Milla CE; Starner TD; Weiner DJ; Lee PS; Ratjen F
    Lancet Respir Med; 2013 Oct; 1(8):630-638. PubMed ID: 24461666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spirometry in early childhood in cystic fibrosis patients.
    Vilozni D; Bentur L; Efrati O; Minuskin T; Barak A; Szeinberg A; Blau H; Picard E; Kerem E; Yahav Y; Augarten A
    Chest; 2007 Feb; 131(2):356-61. PubMed ID: 17296633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.
    Moss RB; Flume PA; Elborn JS; Cooke J; Rowe SM; McColley SA; Rubenstein RC; Higgins M;
    Lancet Respir Med; 2015 Jul; 3(7):524-33. PubMed ID: 26070913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.